MAPK3 and adenocarcinoma: Robust ERK1/2 phosphorylation in the normal mucosa, most prominently in the luminal regions, and markedly reduced phosphorylation of the kinase in adenomas and adenocarcinomas (Figure 1a,b) were observed.